NO323117B1 - Nye imidazolderivater - Google Patents

Nye imidazolderivater Download PDF

Info

Publication number
NO323117B1
NO323117B1 NO20023298A NO20023298A NO323117B1 NO 323117 B1 NO323117 B1 NO 323117B1 NO 20023298 A NO20023298 A NO 20023298A NO 20023298 A NO20023298 A NO 20023298A NO 323117 B1 NO323117 B1 NO 323117B1
Authority
NO
Norway
Prior art keywords
alkyl
compound according
imidazole
compound
halogen
Prior art date
Application number
NO20023298A
Other languages
English (en)
Norwegian (no)
Other versions
NO20023298L (no
NO20023298D0 (no
Inventor
Raimo Virtanen
Antti Haapalinna
Jyrki Lehtimaki
Arto Karjalainen
Paavo Huhtala
Arja Karjalainen
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of NO20023298D0 publication Critical patent/NO20023298D0/no
Publication of NO20023298L publication Critical patent/NO20023298L/no
Publication of NO323117B1 publication Critical patent/NO323117B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20023298A 2000-01-14 2002-07-08 Nye imidazolderivater NO323117B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20000073A FI20000073A0 (fi) 2000-01-14 2000-01-14 Uusia imidatsolijohdannaisia
PCT/FI2001/000030 WO2001051472A1 (en) 2000-01-14 2001-01-12 New imidazole derivatives

Publications (3)

Publication Number Publication Date
NO20023298D0 NO20023298D0 (no) 2002-07-08
NO20023298L NO20023298L (no) 2002-09-06
NO323117B1 true NO323117B1 (no) 2007-01-08

Family

ID=8557065

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023298A NO323117B1 (no) 2000-01-14 2002-07-08 Nye imidazolderivater

Country Status (30)

Country Link
EP (1) EP1261588B1 (et)
JP (1) JP2003519688A (et)
KR (1) KR20020084091A (et)
CN (1) CN1187336C (et)
AR (1) AR029432A1 (et)
AT (1) ATE280161T1 (et)
AU (1) AU769896B2 (et)
BR (1) BR0107644A (et)
CA (1) CA2397283A1 (et)
CZ (1) CZ20022358A3 (et)
DE (1) DE60106572T2 (et)
DK (1) DK1261588T3 (et)
EE (1) EE200200389A (et)
ES (1) ES2228884T3 (et)
FI (1) FI20000073A0 (et)
GC (1) GC0000218A (et)
HK (1) HK1049999B (et)
HU (1) HUP0301008A3 (et)
IL (1) IL150506A0 (et)
MX (1) MXPA02006872A (et)
NO (1) NO323117B1 (et)
NZ (1) NZ519919A (et)
PE (1) PE20011230A1 (et)
PL (1) PL207281B1 (et)
PT (1) PT1261588E (et)
RU (1) RU2265598C2 (et)
SI (1) SI1261588T1 (et)
SK (1) SK286320B6 (et)
WO (1) WO2001051472A1 (et)
ZA (1) ZA200205301B (et)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20002756A0 (fi) * 2000-12-15 2000-12-15 Orion Yhtymae Oyj Uusi hoitomenetelmä
TW200930291A (en) * 2002-04-29 2009-07-16 Bayer Cropscience Ag Pesticidal heterocycles
FI20022159A0 (fi) * 2002-12-05 2002-12-05 Orion Corp Uusia farmaseuttisia yhdisteitä
DE102004035322A1 (de) * 2004-07-21 2006-02-16 Universität des Saarlandes Selektive Hemmstoffe humaner Corticoidsynthasen
ES2381589T3 (es) 2006-10-19 2012-05-29 F. Hoffmann-La Roche Ag Aminometil-4-imidazoles
RU2456281C2 (ru) 2006-11-16 2012-07-20 Ф. Хоффманн-Ля Рош Аг Замещенные 4-имидазолы, способ их получения и их применение
US20080146523A1 (en) 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
AR090557A1 (es) * 2012-04-02 2014-11-19 Orion Corp DERIVADOS IMIDAZOLICOS AGONISTAS ADRENERGICOS a2

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2225782A (en) * 1988-12-09 1990-06-13 Farmos Group Limited Imidazole derivatives useful for treatment of diabetes
GB2244431A (en) * 1990-05-31 1991-12-04 Farmos Oy Treatment of age related memory impairment and other cognitive disorders
US5541211A (en) * 1991-06-18 1996-07-30 Orion-Yhtyma Oy Administration of atipamezole to elicit a yohimbine-like alpha-adrenoreceptor antagonistic noradrenergic transmission
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use
GB9520150D0 (en) * 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
NZ504667A (en) * 1997-12-04 2003-03-28 Allergan Sales Inc Substituted imidazole derivatives having agonist-like activity at alpha 2B or 2B/2C adrenergic receptors
US6503935B1 (en) * 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
TWI283669B (en) * 1999-06-10 2007-07-11 Allergan Inc Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors

Also Published As

Publication number Publication date
NO20023298L (no) 2002-09-06
PT1261588E (pt) 2005-02-28
DK1261588T3 (da) 2005-02-14
WO2001051472A1 (en) 2001-07-19
RU2002121777A (ru) 2004-01-10
EE200200389A (et) 2003-10-15
GC0000218A (en) 2006-03-29
EP1261588A1 (en) 2002-12-04
IL150506A0 (en) 2003-02-12
HK1049999A1 (en) 2003-06-06
RU2265598C2 (ru) 2005-12-10
SI1261588T1 (en) 2005-02-28
ATE280161T1 (de) 2004-11-15
HUP0301008A3 (en) 2004-01-28
CN1187336C (zh) 2005-02-02
PL356884A1 (en) 2004-07-12
DE60106572T2 (de) 2006-02-09
EP1261588B1 (en) 2004-10-20
PL207281B1 (pl) 2010-11-30
ZA200205301B (en) 2003-10-02
AU2853201A (en) 2001-07-24
AR029432A1 (es) 2003-06-25
SK286320B6 (en) 2008-07-07
MXPA02006872A (es) 2003-01-28
JP2003519688A (ja) 2003-06-24
HK1049999B (zh) 2005-05-13
CA2397283A1 (en) 2001-07-19
SK9982002A3 (en) 2003-03-04
AU769896B2 (en) 2004-02-05
ES2228884T3 (es) 2005-04-16
DE60106572D1 (de) 2004-11-25
CN1395567A (zh) 2003-02-05
NO20023298D0 (no) 2002-07-08
PE20011230A1 (es) 2001-12-08
CZ20022358A3 (cs) 2007-12-19
BR0107644A (pt) 2002-10-08
KR20020084091A (ko) 2002-11-04
WO2001051472A9 (en) 2003-01-23
NZ519919A (en) 2003-10-31
FI20000073A0 (fi) 2000-01-14
HUP0301008A2 (hu) 2003-10-28

Similar Documents

Publication Publication Date Title
EP1349839B1 (en) Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
HU224197B1 (hu) Alfa2-receptorokra ható imidazolszármazékok
AU2002229567A1 (en) Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
EP0630374A1 (en) Imidazole, triazole and tetrazole derivatives
HU220088B (hu) Tetrahidro-piridin- (vagy -4-hidroxi-piperidin)-alkil-azol-származékok és alkalmazásuk
NO323117B1 (no) Nye imidazolderivater
US5194440A (en) Substituted cyclic sulphamide derivatives
US6388090B2 (en) Imidazole derivatives
HU205086B (en) Process for producing substituted imidazole derivatives and pharmaceutical compositions comprising such compounds
US4859691A (en) Certain 1,2-benzisoxazole derivatives
US4598086A (en) α2 antagonistic 2-(4,5-dihydro-2-1H-imidazolyl)-2,3-dihydro-1H-indoles
JP2000501070A (ja) 5−HT▲下1Dα▼アゴニストとしての置換インドリルプロピルピペラジン誘導体
JPH11510177A (ja) 置換1−インドリルプロピル−4−フェネチルピペラジン誘導体
US5994374A (en) Substituted 1-indolylpropyl-4-benzyl-tetrahydropyridine derivatives

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees